Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats

Psychopharmacology

Volumn 228, Issue 4, 2013, Pages 659-672

  Brennan, Katharine A ^a   Putt, Fraser ^a   Truman, Penelope ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Addiction; Methamphetamine; Nicotine; Psychostimulant; Rat; Sensitisation

Indexed keywords

METHAMPHETAMINE; NICOTINE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LOCOMOTION; MALE; MOTOR PERFORMANCE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; RAT; SENSITIZATION; TOBACCO DEPENDENCE; TOBACCO PARTICULATE MATTER;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NICOTINE; PARTICULATE MATTER; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SMOKE; TOBACCO;

EID: 84881238061     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3071-3     Document Type: Article

References (109)

1. Airaksinen MM, Kari I (1981) Beta-carbolines, psychoactive compounds in the mammalian body. Part I: occurrence, origin and metabolism. Med Biol 59:21-34
2. Airaksinen MM, Mikkonen E (1980) Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites. Med Biol 58:341-344
3. Ambrose V, Miller JH, Dickson SJ, Hampton S, Truman P, Lea RA, Fowles J (2007) Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells. Nicotine Tob Res 9:793-799
4. Arnold B, Allison K, Ivanova S, Paetsch PR, Paslawski T, Greenshaw AJ (1995) 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats. Psychopharmacol (Berl) 119:213-221
5. Balfour DJ, Wright AE, Benwell ME, Birrell CE (2000) The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113:73-83
6. Ball KT, Klein JE, Plocinski JA, Slack R (2011) Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration. Behav Pharmacol 22:847-850
7. Baum SS, Hill R, Rommelspacher H (1995) Norharman-induced changes of extracellular concentrations of dopamine in the nucleus accumbens of rats. Life Sci 56:1715-1720
8. Baum SS, Hill R, Rommelspacher H (1996) Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. Eur J Pharmacol 314:75-82
9. Baumann MH, Ayestas MA, Sharpe LG, Lewis DB, Rice KC, Rothman RB (2002) Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate. J Pharmacol Exp Ther 301:1190-1197
10. Belluzzi JD, Wang R, Leslie FM (2005) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705-712
11. Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57-71
12. Benwell ME, Balfour DJ (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
13. Borland R, Partos TR, Yong HH, Cummings KM, Hyland A (2012) How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction 107:673-682
14. Bracken AL, Chambers RA, Berg SA, Rodd ZA, McBride WJ (2011) Nicotine exposure during adolescence enhances behavioral sensitivity to nicotine during adulthood in Wistar rats. Pharmacol Biochem Behav 99:87-93
15. Cadoni C, Di Chiara G (2000) Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol 387:R23-R25
16. Calderan L, Chiamulera C, Marzola P, Fabene PF, Fumagalli GF, Sbarbati A (2005) Sub-chronic nicotine-induced changes in regional cerebral blood volume and transversal relaxation time patterns in the rat: a magnetic resonance study. Neurosci Lett 377:195-199
17. Cao R, Peng W, Wang Z, Xu A (2007) beta-Carboline alkaloids: biochemical and pharmacological functions. Curr Med Chem 14:479-500
18. Clarke PB, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337
19. Clemens KJ, Caille S, Stinus L, Cador M (2009) The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol 12:1355-1366
20. Colussi-Mas J, Schenk S (2008) Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Eur J Neurosci 28:1895-1910
21. Coolon RA, Cain ME (2009) Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats. Pharmacol Biochem Behav 93:59-66
22. Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1:11-20
23. Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacol (Berl) 99:473-478
24. Dani JA, De Biasi M (2001) Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70:439-446
25. De La Garza R 2nd, Cunningham KA (2000) The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292:610-617
26. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314
27. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278
28. Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429
29. DiFranza JR, Wellman RJ (2005) A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. Nicotine Tob Res 7:9-26
30. DiFranza JR, Wellman RJ (2007) Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res 9:9-20
31. Domino EF (2001) Nicotine induced behavioral locomotor sensitization. Prog Neuro-Psychopharmacol Biol Psychiatry 25:59-71
32. Donny EC, Caggiula AR, Mielke MM, Jacobs KS, Rose C, Sved AF (1998) Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacol (Berl) 136:83-90
33. Ericson M, Norrsjo G, Svensson AI (2010) Behavioral sensitization to nicotine in female and male rats. J Neural Transm 117:1033-1039
34. Eriksen M, Mackay J, Ross H (2012) The tobacco atlas (Revised 4th Ed). http://wwwtobaccoatlasorg/uploads/Images/PDFs/Tobacco-Atlas-2ndPrintpdf Accessed Jan 2013
35. Faraday MM, Scheufele PM, Rahman MA, Grunberg NE (1999) Effects of chronic nicotine administration on locomotion depend on rat sex and housing condition. Nicotine Tob Res 1:143-151
36. Faraday MM, Elliott BM, Phillips JM, Grunberg NE (2003) Adolescent and adult male rats differ in sensitivity to nicotine's activity effects. Pharmacol Biochem Behav 74:917-931
37. Fekkes D, Bode WT (1993) Occurrence and partition of the beta-carboline norharman in rat organs. Life Sci 52:2045-2054
38. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736
39. Fowler JS, Volkow ND, Logan J, Pappas N, King P, MacGregor R, Shea C, Garza V, Gatley SJ (1998a) An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. Life Sci 63:PL19-PL23
40. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I (1998b) Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis 17:23-34
41. Fowler JS, Logan J, Wang GJ, Volkow ND (2003) Monoamine oxidase and cigarette smoking. NeuroToxicology 24:75-82
42. Fowles JB, M (2000) The chemical consitituents in cigarette and cigarette smoke: priorities for harm reduction. Ministry of Health New Zealand. http://wwwmohgovtnz/mohnsf/pagescm/1003/File/ chemicalconstituentscigarettesprioritiespdf Accessed Jan 2013
43. Gerard N, Ceccarini J, Bormans G, Vanbilloen B, Casteels C, Goffin K, Bosier B, Lambert DM, Van Laere K (2010) Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470. J Mol Neurosci 42:162-167
44. Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacol (Berl) 157:292-298
45. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25:8593-8600
46. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2006) Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci 24:3532-3540
47. Hahn B, Stolerman IP, Shoaib M (2000) Kappa-opioid receptor modulation of nicotine-induced behaviour. Neuropharmacology 39:2848-2855
48. Harris AC, Stepanov I, Pentel PR, Lesage MG (2012) Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement- attenuating and discriminative stimulus effects in rats. Psychopharmacol (Berl) 220:565-576
49. Hawkins J, Hollingworth W, Campbell R (2010) Long-term smoking relapse: a study using the British household panel survey. Nicotine Tob Res 12:1228-1235
50. Herraiz T (2004) Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit Contam 21:1041-1050
51. Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378-386
52. Hong SK, Jung IS, Bang SA, Kim SE (2006) Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. Neurosci Lett 409:220-223
53. Husbands SM, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, Nutt DJ, Lewis JW, Hudson AL (2001) Beta-carboline binding to imidazoline receptors. Drug Alcohol Depend 64:203-208
54. Iyaniwura TT, Wright AE, Balfour DJ (2001) Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain. Psychopharmacol (Berl) 158:73-79
55. Kelsey JE, Beer T, Lee E, Wagner A (2002) Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats. Psychopharmacol (Berl) 161:370-378
56. Kempsill FE, Pratt JA (2000) Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine. Br J Pharmacol 131:997-1003
57. Kerr DC, Owen LD, Capaldi DM (2011) The timing of smoking onset, prolonged abstinence and relapse in men: a prospective study from ages 18 to 32 years. Addiction 106:2031-2038
58. Ksir C (1994) Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis. Psychopharmacol (Berl) 115:105-109
59. Ksir C, Hakan R, Hall DP Jr, Kellar KJ (1985) Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology 24:527-531
60. Lanteri C, Hernandez Vallejo SJ, Salomon L, Doucet EL, Godeheu G, Torrens Y, Houades V, Tassin JP (2009) Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization. J Neurosci 29:987-997
61. Lewis AJ, Truman P, Hosking MR, Miller JH (2012) Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type. Tob Control 21:39-43
62. Li Z, DiFranza JR, Wellman RJ, Kulkarni P, King JA (2008) Imaging brain activation in nicotine-sensitized rats. Brain Res 1199:91-99
63. MacInnes N, Handley SL (2002) Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. Br J Pharmacol 135:1227-1234
64. Maciuk A, Moaddel R, Haginaka J, Wainer IW (2008) Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography. J Pharm Biomed Anal 48:238-246
65. McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors. J Pharmacol Exp Ther 290:965-973
66. Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP (2001) Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacol (Berl) 156:469-476
67. Miller DK, Harrod SB, Green TA, Wong MY, Bardo MT, Dwoskin LP (2003) Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats. Pharmacol Biochem Behav 74:279-286
68. Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, Garcia-Sevilla JA (2005) High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. Eur J Pharmacol 518:234-242
69. Miyata H, Ando K, Yanagita T (1996) Comparison of the effects of nicotine and methamphetamine on extracellular dopamine in the nucleus accumbens of behaviorally sensitized rats. Nihon Shinkei Seishin Yakurigaku Zasshi 16:41-47
70. Morin AM, Watson AL, Wasterlain CG (1983) Kindling of seizures with norharman, a beta-carboline ligand of benzodiazepine receptors. Eur J Pharmacol 88:131-134
71. Morrison CF, Stephenson JA (1972) The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol 46:151-156
72. Musgrave IF, Badoer E (2000) Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors. Br J Pharmacol 129:1057-1059
73. Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH (1996) Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22:369-381
74. Okuyemi KS, Ahluwalia JS, Harris KJ (2000) Pharmacotherapy of smoking cessation. Arch Fam Med 9:270-281
75. Olausson P, Akesson P, Engel JA, Soderpalm B (2001a) Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur J Pharmacol 420:45-54
76. Olausson P, Akesson P, Petersson A, Engel JA, Soderpalm B (2001b) Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacol (Berl) 155:348-361
77. Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF (2007) The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine. Neuropsychopharmacology 32:1098-1108
78. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH (1996) Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133-142
79. Paulus MP, Callaway CW, Geyer MA (1993) Quantitative assessment of the microstructure of rat behavior: II. Distinctive effects of dopamine releasers and uptake inhibitors. Psychopharmacol (Berl) 113:187-198
80. Pawlik M, Kaulen P, Baumgarten HG, Rommelspacher H (1990) Quantitative autoradiography of [3H]norharman [(3H]beta-carboline) binding sites in the rat brain. J Chem Neuroanat 3:19-24
81. Pfau W, Skog K (2004) Exposure to beta-carbolines norharman and harman. J Chromatogr B Anal Technol Biomed Life Sci 802:115-126
82. Piasecki TM (2006) Relapse to smoking. Clin Psychol Rev 26:196-215
83. Pich EM, Pagliusi SR, Tessari M, Talabot-Ayer D, Hooft van Huijsduijnen R, Chiamulera C (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science 275:83-86
84. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257
85. Reavill C, Stolerman IP (1990) Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99:273-278
86. Reid MS, Ho LB, Berger SP (1996) Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis. Psychopharmacol (Berl) 126:301-310
87. Rigotti NA (2002) Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346:506-512
88. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291
89. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103-114
90. Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Muller WE, Wollert U (1980) 1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn Schmiedeberg's Arch Pharmacol 314:97-100
91. Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Muller WE, Wollert U (1981) Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo. Eur J Pharmacol 70:409-416
92. Rommelspacher H, May T, Salewski B (1994) Harman (1-methyl-beta- carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 252:51-59
93. Rommelspacher H, Meier-Henco M, Smolka M, Kloft C (2002) The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur J Pharmacol 441:115-125
94. Shim I, Javaid JI, Wirtshafter D, Jang SY, Shin KH, Lee HJ, Chung YC, Chun BG (2001) Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav Brain Res 121:137-147
95. Shim I, Kim HT, Kim YH, Chun BG, Hahm DH, Lee EH, Kim SE, Lee HJ (2002) Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Eur J Pharmacol 443:119-124
96. Shoaib M, Benwell ME, Akbar MT, Stolerman IP, Balfour DJ (1994) Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br J Pharmacol 111:1073-1080
97. Sorge RE, Clarke PB (2009) Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists. J Pharmacol Exp Ther 330:633-40.
98. Stedman RL (1968) The chemical composition of tobacco and tobacco smoke. Chem Rev 68:153-207
99. Steketee JD, Kalivas PW (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63:348-365
100. Sziraki I, Sershen H, Benuck M, Lipovac M, Hashim A, Cooper TB, Allen D, Lajtha A (1999) The effect of cotinine on nicotine- and cocaine-induced dopamine release in the nucleus accumbens. Neurochem Res 24:1471-1478
101. Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R (2005) Harmane inhibits serotonergic dorsal raphe neurons in the rat. Psychopharmacol (Berl) 182:562-569
102. Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R (2007) Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. NeuroReport 18:925-929
103. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN (1999) A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19:9579-9586
104. Vaupel DB, Stein EA, Mukhin AG (2007) Quantification of alpha4beta2 nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380. NeuroImage 34:1352-1362
105. Vezina P, McGehee DS, Green WN (2007) Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuro-Psychopharmacol Biol Psychiatry 31:1625-1638
106. Villegier AS, Blanc G, Glowinski J, Tassin JP (2003) Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav 76:267-274
107. Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM (2007) Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52:1415-1425
108. Villegier AS, Gallager B, Heston J, Belluzzi JD, Leslie FM (2010) Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats. Psychopharmacol (Berl) 208:593-601
109. Zaniewska M, McCreary AC, Wydra K, Filip M (2010) Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment. Synapse 64:511-519